Literature DB >> 9646784

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy.

J M Walenga1, R L Bick.   

Abstract

Although several new anticoagulant drugs are in development, heparin remains the drug of choice for most anticoagulation needs. The clinical effects of heparin are meritorious, but side effects do exist. Important untoward effects of heparin therapy including heparin-induced thrombocytopenia, heparin-associated osteoporosis, eosinophilia, skin reactions, allergic reactions other than thrombocytopenia and alopecia will be discussed in this article.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646784     DOI: 10.1016/s0025-7125(05)70015-8

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

1.  Red blood cell-mimicking synthetic biomaterial particles.

Authors:  Nishit Doshi; Alisar S Zahr; Srijanani Bhaskar; Joerg Lahann; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

2.  Dural Sinus Thrombosis Complicated with Heparin Induced Thrombocytopenia and Thrombosis (HITT).

Authors:  S K Lee; R Willinsky; K Terbrugge
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

3.  Successful Use of Alternative Anticoagulants in the Management of Heparin-induced Thrombocytopenia with Thrombotic Complications: Report of 5 cases and review of literature.

Authors:  Salam Alkindi; Owen P Smith; Helen Enright
Journal:  Sultan Qaboos Univ Med J       Date:  2011-08-15

Review 4.  Low molecular weight heparin-induced skin necrosis-a systematic review.

Authors:  A E Handschin; O Trentz; H J Kock; G A Wanner
Journal:  Langenbecks Arch Surg       Date:  2004-11-27       Impact factor: 3.445

Review 5.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

6.  A botanical medicine dragon's blood exhibited clinical antithrombosis efficacy similar to low molecular weight heparin.

Authors:  Jiangbin Liang; Song Mei; Xiangyu Qiao; Wei Pan; Yan Zhao; Shaohui Shi; Yaling Zhai; Haizhao Wen; Guoping Wu; Chengyu Jiang
Journal:  Sci China Life Sci       Date:  2021-01-29       Impact factor: 6.038

Review 7.  Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism.

Authors:  R L Bick
Journal:  Drugs       Date:  2000-09       Impact factor: 11.431

8.  The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.

Authors:  Gandhi N Solayar; Pauline M Walsh; Kevin J Mulhall
Journal:  BMC Musculoskelet Disord       Date:  2011-10-28       Impact factor: 2.362

9.  The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis.

Authors:  Melanie Timmen; Heriburg Hidding; Martin Götte; Thaqif El Khassawna; Daniel Kronenberg; Richard Stange
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

10.  Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model.

Authors:  Peter Michael Prodinger; Rainer Burgkart; Kilian Kreutzer; Franz Liska; Hakan Pilge; Andreas Schmitt; Martina Knödler; Boris Michael Holzapfel; Alexander Hapfelmeier; Thomas Tischer; Oliver Bissinger
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.